SIGA Technologies, Inc. (NASDAQ:SIGA - Get Free Report) saw unusually large options trading activity on Wednesday. Stock traders purchased 1,200 call options on the company. This is an increase of approximately 1,438% compared to the average volume of 78 call options.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the business. Larson Financial Group LLC bought a new stake in shares of SIGA Technologies during the third quarter worth about $30,000. DekaBank Deutsche Girozentrale acquired a new position in SIGA Technologies during the 2nd quarter valued at about $40,000. EP Wealth Advisors LLC bought a new stake in SIGA Technologies during the 3rd quarter worth approximately $82,000. XTX Topco Ltd purchased a new stake in shares of SIGA Technologies in the third quarter worth approximately $85,000. Finally, AQR Capital Management LLC bought a new position in shares of SIGA Technologies in the second quarter valued at approximately $99,000. Institutional investors and hedge funds own 55.40% of the company's stock.
SIGA Technologies Trading Down 0.2 %
SIGA Technologies stock traded down $0.01 during midday trading on Thursday, reaching $6.28. The stock had a trading volume of 311,464 shares, compared to its average volume of 500,944. The company has a fifty day moving average price of $6.55 and a two-hundred day moving average price of $7.62. SIGA Technologies has a 12 month low of $4.26 and a 12 month high of $12.83. The company has a market capitalization of $448.42 million, a P/E ratio of 5.23 and a beta of 0.94.
SIGA Technologies (NASDAQ:SIGA - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.02 EPS for the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. The firm had revenue of $10.01 million during the quarter. On average, equities research analysts predict that SIGA Technologies will post 1.04 earnings per share for the current fiscal year.
About SIGA Technologies
(
Get Free Report)
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
See Also
Before you consider SIGA Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SIGA Technologies wasn't on the list.
While SIGA Technologies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
